These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4398226)

  • 41. Effects of a new cardioselective beta-adrenergic blocker (tolamolol) on exercise tolerance in patients with angina pectoris.
    Sood NK; Havard CW
    Thorax; 1973 May; 28(3):331-4. PubMed ID: 4146782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of alprenolol in the treatment of angina pectoris].
    Lippenholtz A; Talmasky S; Berconsky I
    Prensa Med Argent; 1969 Sep; 56(27):1357-61. PubMed ID: 4391256
    [No Abstract]   [Full Text] [Related]  

  • 43. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A; Gregorini L; Valentini R
    Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical trials of anti-angina drugs].
    Camerini E; Alberti E; Borgioni L; Medugno G; Scardi S
    G Ital Cardiol; 1976; 6(7):1291-304. PubMed ID: 13024
    [No Abstract]   [Full Text] [Related]  

  • 45. [Eraldin: a cardioselective beta-adrenergic receptor blocking agent in the treatment of angina pectoris].
    Musial W; Krzemińska-Pakula M; Tracz W
    Pol Tyg Lek; 1971 Aug; 26(34):1316-8. PubMed ID: 4398697
    [No Abstract]   [Full Text] [Related]  

  • 46. -Receptor antagonists in angina pectoris.
    Prichard BN
    Ann Clin Res; 1971 Dec; 3(6):344-52. PubMed ID: 4400460
    [No Abstract]   [Full Text] [Related]  

  • 47. [Clinical experiences with a new beta-sympatholytic agent Kö 1366 (bunitrolol)].
    Wallnöfer H; Täuber K
    Wien Med Wochenschr; 1974 Sep; 124(38):550-7. PubMed ID: 4153181
    [No Abstract]   [Full Text] [Related]  

  • 48. [Cardiovascular-active agents. Problems of dosage and adverse effects].
    Baedeker W
    Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):315-9. PubMed ID: 4402116
    [No Abstract]   [Full Text] [Related]  

  • 49. [Remote results of treatment of angina pectoris with various types of drugs blocking beta adrenergic receptors].
    Musial W; Krzemińska-Pakula M; Tracz W
    Pol Tyg Lek; 1972 May; 27(20):752-4. PubMed ID: 4402234
    [No Abstract]   [Full Text] [Related]  

  • 50. Antiarrhythmic effectiveness of alprenolol, a new beta adrenergic receptor blocking agent.
    Schwartz ML; Haider B; Covino BG; Co RG
    J Electrocardiol; 1970; 3(3-4):211-6. PubMed ID: 4397112
    [No Abstract]   [Full Text] [Related]  

  • 51. Intravenous practolol.
    Jachuck SJ; Husaini MH
    Br Med J; 1971 Oct; 4(5782):298. PubMed ID: 4399381
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effects of an adrenergic beta receptor blockader on exercise tolerance and myocardial function in patients with angina pectoris].
    De Petra V; Di Michele R; Cecchetti E
    Minerva Cardioangiol; 1973 Sep; 21(9):619-24. PubMed ID: 4745004
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical evaluation of adrenergic beta blocking agents in angina pectoris in a double blind trial].
    Saad EA; Prazeres PR; Siqueira PL; Amarante A; Levy S; Benchimol AB
    Arq Bras Cardiol; 1971 Feb; 24(1):7-16. PubMed ID: 4399358
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of angina pectoris with cardioselective beta blocking agents. Double blind study with Eraldin (practolol)].
    Erikssen J; Rod T
    Tidsskr Nor Laegeforen; 1971 Apr; 91(10):721-5. PubMed ID: 4397025
    [No Abstract]   [Full Text] [Related]  

  • 55. The clinical effect of 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine (BAY a 1040) on angina pectoris evaluated by sequential analysis.
    Kimura E; Mabuchi G; Kikuchi H
    Arzneimittelforschung; 1972 Feb; 22(2):365-7. PubMed ID: 4623700
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effects of acute administration of the levogyral beta-blocker levomoprolol on the exercise test in angina pectoris].
    Lai C; Tallu B; Onnis E; Pirisi R; Cioglia G; Cherchi A
    Cardiologia; 1984 Dec; 29(12):605-14. PubMed ID: 6152549
    [No Abstract]   [Full Text] [Related]  

  • 57. [Silent myocardial ischemia. Arguments against treatment].
    Rayo Llerena I; Marín Huerta E
    Rev Esp Cardiol; 1996 Jan; 49(1):6-12. PubMed ID: 8685514
    [No Abstract]   [Full Text] [Related]  

  • 58. Prophylactic treatment of angina pectoris. A double-blind cross-over comparison of alprenolol and pentanitrol.
    Aubert A; Nyberg G; Slaastad R; Tjeldflaat L
    Br Med J; 1970 Jan; 1(5690):203-6. PubMed ID: 4391702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Aptin, Hässle (Alprenolol)].
    Saunamäki K
    Ugeskr Laeger; 1969 Sep; 131(36):1527-9. PubMed ID: 5356458
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical trial of anti-angina drugs in Italy (1963-1974)].
    Scardi S; Alberti E; Borgioni L; Camerini F
    G Ital Cardiol; 1976; 6(6):978-86. PubMed ID: 14863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.